Cetuximab Every 2 Weeks with First-Line Chemotherapy in APEC Study Patients with Metastatic Colorectal Cancer Grouped According to EGFR Expression
Titel:
Cetuximab Every 2 Weeks with First-Line Chemotherapy in APEC Study Patients with Metastatic Colorectal Cancer Grouped According to EGFR Expression
Auteur:
Cheng, A.L. Cornelio, G. Shen, L. Price, T. Yang, T.S. Chung, I.J. Dai, G.H. Lin, J.K. Sharma, A. Yeh, K.H. Ma, B. Zaatar, A. Guan, Z.Z. Masood, N. Srimuninnimit, V. Yau, T. Beier, F. Chatterjee, S. Lim, R.